# A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

> **NCT06685887** · PHASE2 · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 34 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** HIPEC
- **DRUG:** SOX
- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT06685887
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06685887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06685887, "A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06685887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*